Global and China Anti Obesity Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Anti Obesity Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Arena Pharmaceuticals

    • Zafgan

    • Norgine

    • GlaxoSmithKline

    • Pfizer

    • Boehringer Ingelheim

    • Rhythm Pharmaceuticals

    • Novo Nordisk

    • Orexigen Therapeutics

    • AstraZeneca

    • Shionogi

    • Merck

    • Vivus

    • Roche

    • Eisai

    • Alizyme

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral Medicine

    • Diet Patch

    • Other

    Application:

    • Men

    • Women

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Anti Obesity Drugs Industry Overview

      • 1.1.1 Anti Obesity Drugs Market Scope and Market Segments

      • 1.1.2 Anti Obesity Drugs Industry Characteristics

      • 1.1.3 Global and China Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Anti Obesity Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Anti Obesity Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral Medicine

      • 1.2.2 Diet Patch

      • 1.2.3 Other

    • 1.3 Global Anti Obesity Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Men

      • 1.3.2 Women

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Anti Obesity Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Anti Obesity Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Anti Obesity Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Anti Obesity Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Anti Obesity Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Anti Obesity Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Anti Obesity Drugs Industry PEST Analysis

    • 2.3 Anti Obesity Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Anti Obesity Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Anti Obesity Drugs Industry

    Chapter 3 Global and China Anti Obesity Drugs Market, by Manufacturer

    • 3.1 Global and China Anti Obesity Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Anti Obesity Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Anti Obesity Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Anti Obesity Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Anti Obesity Drugs Market Top 3 Players

    Chapter 4 Global and China Anti Obesity Drugs Market, by Type (2017-2028)

    • 4.1 Anti Obesity Drugs Market Trend, by Type

    • 4.2 Global Anti Obesity Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Anti Obesity Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Anti Obesity Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Anti Obesity Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Anti Obesity Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Anti Obesity Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Anti Obesity Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Anti Obesity Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Anti Obesity Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Anti Obesity Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Anti Obesity Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Anti Obesity Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Anti Obesity Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Anti Obesity Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Anti Obesity Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Anti Obesity Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Anti Obesity Drugs Market Analysis

    • 7.1 North America Anti Obesity Drugs Market, by Type

    • 7.2 North America Anti Obesity Drugs Market, by Application

    • 7.3 North America Anti Obesity Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Anti Obesity Drugs Market Analysis

    • 8.1 Europe Anti Obesity Drugs Market, by Type

    • 8.2 Europe Anti Obesity Drugs Market, by Application

    • 8.3 Europe Anti Obesity Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Anti Obesity Drugs Market Analysis

    • 9.1 APAC Anti Obesity Drugs Market, by Type

    • 9.2 APAC Anti Obesity Drugs Market, by Application

    • 9.3 APAC Anti Obesity Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Anti Obesity Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Anti Obesity Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Anti Obesity Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Anti Obesity Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Anti Obesity Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Anti Obesity Drugs Company Profiles

      • 11.1 Arena Pharmaceuticals

        • 11.1.1 Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Arena Pharmaceuticals Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.1.3 Arena Pharmaceuticals Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Zafgan

        • 11.2.1 Zafgan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Zafgan Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.2.3 Zafgan Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Norgine

        • 11.3.1 Norgine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Norgine Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.3.3 Norgine Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline

        • 11.4.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Pfizer

        • 11.5.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Pfizer Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.5.3 Pfizer Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Boehringer Ingelheim

        • 11.6.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Boehringer Ingelheim Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Rhythm Pharmaceuticals

        • 11.7.1 Rhythm Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Rhythm Pharmaceuticals Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.7.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Novo Nordisk

        • 11.8.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Novo Nordisk Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.8.3 Novo Nordisk Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Orexigen Therapeutics

        • 11.9.1 Orexigen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Orexigen Therapeutics Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.9.3 Orexigen Therapeutics Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 AstraZeneca

        • 11.10.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 AstraZeneca Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.10.3 AstraZeneca Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Shionogi

        • 11.11.1 Shionogi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Shionogi Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.11.3 Shionogi Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Merck

        • 11.12.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Merck Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.12.3 Merck Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Vivus

        • 11.13.1 Vivus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Vivus Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.13.3 Vivus Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Roche

        • 11.14.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Roche Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.14.3 Roche Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Eisai

        • 11.15.1 Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Eisai Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.15.3 Eisai Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Alizyme

        • 11.16.1 Alizyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Alizyme Anti Obesity Drugs Product Profiles, Application and Specification

        • 11.16.3 Alizyme Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Anti Obesity Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Anti Obesity Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Anti Obesity Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Anti Obesity Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Anti Obesity Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Anti Obesity Drugs Market Size and Growth Rate of Oral Medicine (2017-2028)

    • Figure Global Anti Obesity Drugs Market Size and Growth Rate of Diet Patch (2017-2028)

    • Figure Global Anti Obesity Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Anti Obesity Drugs Market Size and Growth Rate of Men (2017-2028)

    • Figure Global Anti Obesity Drugs Market Size and Growth Rate of Women (2017-2028)

    • Figure North America Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Anti Obesity Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Anti Obesity Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Anti Obesity Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Anti Obesity Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Anti Obesity Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Anti Obesity Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Anti Obesity Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Anti Obesity Drugs Market Share, by Manufacturer in 2022

    • Table Global Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table Global Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Anti Obesity Drugs Sales Value, by Type (2017-2028)

    • Table Global Anti Obesity Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Anti Obesity Drugs Price Trend, by Type (2017-2028)

    • Table China Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table China Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Anti Obesity Drugs Sales Value, by Type (2017-2028)

    • Table China Anti Obesity Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Anti Obesity Drugs Price Trend, by Type (2017-2028)

    • Table Global Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table Global Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Anti Obesity Drugs Sales Value, by Application (2017-2028)

    • Table Global Anti Obesity Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Anti Obesity Drugs Sales Value Share, by Application (2017-2028)

    • Table China Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table China Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Anti Obesity Drugs Sales Value, by Application (2017-2028)

    • Table China Anti Obesity Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Anti Obesity Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Anti Obesity Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table North America Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table North America Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Anti Obesity Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Anti Obesity Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Anti Obesity Drugs Sales Value and Growth Rate (2017-2028)

    • Table Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arena Pharmaceuticals Product Profiles, Application and Specification

    • Table Arena Pharmaceuticals Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zafgan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zafgan Product Profiles, Application and Specification

    • Table Zafgan Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Norgine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Norgine Product Profiles, Application and Specification

    • Table Norgine Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Rhythm Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Rhythm Pharmaceuticals Product Profiles, Application and Specification

    • Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Orexigen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orexigen Therapeutics Product Profiles, Application and Specification

    • Table Orexigen Therapeutics Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shionogi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shionogi Product Profiles, Application and Specification

    • Table Shionogi Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Vivus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Vivus Product Profiles, Application and Specification

    • Table Vivus Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eisai Product Profiles, Application and Specification

    • Table Eisai Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alizyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alizyme Product Profiles, Application and Specification

    • Table Alizyme Anti Obesity Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.